Trinity Life Sciences and Havas Health & You, A New Strategic Partnership

Trinity Life Sciences and Havas Health & You, A New Strategic Partnership

Trinity Life Sciences and Havas Health & You, A Best New Strategic Partnership 2023 | The Lifesciences Magazine

INTRODUCTION

Today, Trinity Life Sciences and Havas Health & You (HHY&Y), the world’s largest global health and wellness network and part of Havas Group, a Vivendi (VIV) business, announced a strategic partnership that will allow both companies to provide comprehensive end-to-end commercial solutions to the life sciences industry.

Trinity Life Sciences is a global leader in life sciences solutions. Havas Health & You (HHY&Y) is the world’s largest global health and wellness network. In accordance with the terms of the collaboration, Havas Health & You will make a minority investment in Trinity.

“Contemporary technology is helping to drive tremendous advancements in health, and although this brings along new problems, our alliance allows us to better address the industry’s demands,”

“In order to keep up with the fast-paced and ever-changing nature of the life sciences business, we need to adopt a more holistic perspective in order to work more efficiently and more quickly. According to Donna Murphy, Global CEO of Havas Creative Group and Havas Health & You, “the merger of Trinity and Havas Health & You gives really best in class experience and capabilities across all phases of the pre-commercial and commercial lifecycle.”

“Contemporary technology is helping to drive tremendous advancements in health, and although this brings along new problems, our alliance allows us to better address the industry’s demands,”

“As soon as we began having discussions regarding the possibility of forming a relationship, it became abundantly evident that Trinity and Havas Health & You shared goals that were completely congruent with one another. “Both organizations are aware that every action has the potential to touch a life, and the knowledge of this is what motivates us to get out of bed in the morning,” said David Fitzhenry, Chief Executive Officer of Trinity Life Sciences.

Trinity Life Sciences and Havas Health & You, A Best New Strategic Partnership 2023 | The Lifesciences Magazine

It will be a game-changer for the industry if we add sophisticated data, insights, and analytics to the branding and marketing initiatives that we run for our collective life science customers. Our primary emphasis will be on addressing important aspects of omnichannel retailing, such as the launch, the customer experience, and the implementation of new technology.

The cooperation between Trinity and Havas is the most recent in a series of strategic initiatives made by Trinity. During the course of the previous year, Trinity completed the acquisition of D Cube Analytics, a supplier of data science and analytics, and established a relationship with Bain & Company. The inclusion of HH&Y contributes to the expansion of an already exceptional product, elevating it to the position of best in class.

According to Matt Jennings, Operating Partner of Kohlberg & Co. and Chairman of Trinity Life Sciences, “The relationship is a strategic step for both Trinity and Havas and will assist to change how brands are formed for life sciences firms.” Havas is a French advertising agency. “Customers will see products that handle new product planning initiatives with earlier stage strategic brand messaging. In addition, marketing campaigns that are driven more directly by objective data and analytics will be made available to customers.”

1. About Havas Health & You

Havas Life, Health4Brands (H4B), Lynx, Red Havas, and Havas Health Plus are all health and communications networks that are completely owned by Havas. Havas Health & You brings together these totally owned networks together with the consumer health companies and practices of Havas Creative Group.

Trinity Life Sciences and Havas Health & You, A Best New Strategic Partnership 2023 | The Lifesciences Magazine

The strategy of the network is based on the concept of Human Purpose, and it has the talent, tenacity, and technology that are necessary for health organizations, brands, and individuals to survive in the modern world. Visit www.HavasHealthandYou.com for more details and information.

2. About Trinity Life Sciences

Trinity Life Sciences is a reliable strategic commercialization partner that offers solutions for the life sciences industry that are supported by evidence. Trinity is dedicated to changing the commercial model by offering high levels of service, sophisticated tools, and data-driven insights. With 25 years of industry expertise, Trinity has what it takes to make this happen.

Trinity Life Sciences and Havas Health & You, A Best New Strategic Partnership 2023 | The Lifesciences Magazine

The portfolio of goods and solutions offered by Trinity includes solutions that are at the forefront of benchmarking in their field and are driven by TGaS Advisors. Visit trinitylifesciences.com to read more about how Trinity is advancing evidence-based practice in the life sciences and improving the field as a whole.

Comments

Post a Comment

Popular posts from this blog

15 Best Tasting Protein Shakes That Make Dieting Feel Like Having Dessert

Image
Sick of chalky protein? Get the 15 best tasting protein shakes, like Fairlife Core Power Chocolate and Boost Plus Rich Chocolate that feel like dessert, making dieting easy & delicious!  Source: View more by pixelshot The road to a healthier lifestyle often feels like a path paved with self-denial. We’ve all been there, staring longingly at a slice of cake while nursing a watery, flavorless shake. That is where the battle for your willpower is usually lost. But that’s where the best tasting protein shakes feel like an escape from pain and suffering. But what if you could have your cake and sip it too? Imagine a creamy, decadent liquid that feels less like a supplement and more like a secret treat. Forget the chalky aftertaste of yesteryear—the new generation of protein powders is here. These powders are changing strict dieting into a delightful experience. Get ready to discover the best tasting protein shakes that will make your weight loss journey feel, quite literally, like d...
Read more

The Ultimate Guide To The Best Protein For Building Muscle (2025): Science, Timing, And Real Results

Image
What’s really the best protein for building muscle? The answer goes beyond just whey or casein, learn which one your body responds to fastest for real, lasting muscle gains. Source: View more by Elnur “Muscles are built in the gym, but they grow in the kitchen.” If you’re trying to build muscle, protein is your best friend. Every time you lift weights or push through a tough workout, tiny tears form in your muscle fibers. Your body repairs those tears with the help of protein, and that’s how muscles grow stronger and bigger. Simply put, without enough protein, your hard work in the gym doesn’t pay off. A recent study by the Journal of the International Society of Sports Nutrition found that people who ate 1.6 to 2.2 grams of protein per kilogram of body weight daily gained up to 25% more lean muscle than those who didn’t eat enough. That’s a huge difference and proof that protein isn’t just a trend; it’s science. But here’s where things get confusing. Walk into any supplement store and...
Read more

Novo Nordisk Alzheimer’s results to test GLP-1 potential

Image
Source: www.reuters.com Key Points: Novo Nordisk Alzheimer’s trials are testing whether GLP-1 drugs like Rybelsus can slow cognitive decline in mild Alzheimer’s. The studies aim to clarify how GLP-1 drugs affect the brain and guide future research. Positive results could offer an oral alternative to current treatments and impact Novo’s market outlook. Studies from Novo Nordisk due early next month are expected to offer the clearest evidence so far on whether GLP-1 drugs, widely used for diabetes and weight loss, can slow cognitive decline in Alzheimer’s disease. The Novo Nordisk Alzheimer’s trials are evaluating the oral diabetes drug Rybelsus in two large trials involving thousands of people with mild Alzheimer’s. The data will be presented on Dec. 3 in San Diego at the Clinical Trials on Alzheimer’s Disease meeting. The studies aim to determine whether semaglutide, the active ingredient in Rybelsus, Ozempic and Wegovy, can reduce the rate of cognitive decline by at least 20%. Analyst...
Read more